Forte Biosciences IncNASDAQ:FBRXNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.3227
- TODAY'S CHANGE (%)0.0227 (7.5663%)
- Bid / Lots0.3200/ 20
- Ask / Lots0.3254/ 1
- Open / Previous Close0.3101 / 0.3000
- Day Range
- 52 Week Range
- Volume222,291
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FBRX |
|---|---|---|
| 09:32 ET | 1417 | 0.3101 |
| 09:38 ET | 3400 | 0.3085 |
| 09:41 ET | 200 | 0.3066 |
| 09:52 ET | 744 | 0.3066 |
| 09:57 ET | 1113 | 0.308 |
| 09:59 ET | 15654 | 0.3 |
| 10:03 ET | 200 | 0.304 |
| 10:14 ET | 100 | 0.292 |
| 10:15 ET | 500 | 0.304 |
| 10:24 ET | 1000 | 0.303 |
| 10:26 ET | 154 | 0.303 |
| 10:30 ET | 100 | 0.298001 |
| 10:50 ET | 671 | 0.292001 |
| 10:53 ET | 388 | 0.292 |
| 11:06 ET | 100 | 0.3 |
| 11:15 ET | 500 | 0.2976 |
| 11:18 ET | 100 | 0.2921 |
| 11:29 ET | 1680 | 0.299999 |
| 11:33 ET | 100 | 0.2921 |
| 11:54 ET | 7090 | 0.3 |
| 11:56 ET | 400 | 0.3 |
| 12:00 ET | 700 | 0.3 |
| 12:02 ET | 2100 | 0.304 |
| 12:03 ET | 1398 | 0.3047 |
| 12:09 ET | 5996 | 0.304101 |
| 12:21 ET | 2054 | 0.304 |
| 12:30 ET | 11000 | 0.302 |
| 12:32 ET | 400 | 0.3 |
| 12:36 ET | 200 | 0.302 |
| 12:38 ET | 600 | 0.302 |
| 12:39 ET | 7142 | 0.304 |
| 12:41 ET | 3250 | 0.3039 |
| 12:43 ET | 43610 | 0.3069 |
| 12:45 ET | 400 | 0.3069 |
| 12:48 ET | 500 | 0.3069 |
| 12:50 ET | 500 | 0.3084 |
| 12:52 ET | 500 | 0.3084 |
| 12:54 ET | 400 | 0.3084 |
| 12:56 ET | 500 | 0.3084 |
| 12:57 ET | 400 | 0.3084 |
| 12:59 ET | 100 | 0.3084 |
| 01:06 ET | 207 | 0.3069 |
| 01:10 ET | 3148 | 0.3088 |
| 01:19 ET | 2400 | 0.3227 |
| 01:26 ET | 200 | 0.307 |
| 01:30 ET | 2400 | 0.3227 |
| 01:33 ET | 400 | 0.3148 |
| 01:39 ET | 2400 | 0.3254 |
| 01:50 ET | 2400 | 0.3254 |
| 02:00 ET | 21800 | 0.31645 |
| 02:02 ET | 600 | 0.31645 |
| 02:04 ET | 700 | 0.3164 |
| 02:06 ET | 600 | 0.31645 |
| 02:08 ET | 800 | 0.31645 |
| 02:09 ET | 500 | 0.31645 |
| 02:11 ET | 700 | 0.31645 |
| 02:13 ET | 600 | 0.31645 |
| 02:15 ET | 600 | 0.31645 |
| 02:18 ET | 500 | 0.31645 |
| 02:20 ET | 800 | 0.31645 |
| 02:22 ET | 700 | 0.31645 |
| 02:24 ET | 600 | 0.31645 |
| 02:26 ET | 500 | 0.31645 |
| 02:27 ET | 700 | 0.31645 |
| 02:29 ET | 600 | 0.31645 |
| 02:31 ET | 900 | 0.31645 |
| 02:33 ET | 800 | 0.31645 |
| 02:36 ET | 800 | 0.31645 |
| 02:38 ET | 3290 | 0.31645 |
| 02:40 ET | 700 | 0.31645 |
| 02:42 ET | 1600 | 0.31645 |
| 02:44 ET | 800 | 0.3164 |
| 02:45 ET | 700 | 0.31645 |
| 02:47 ET | 1900 | 0.3167 |
| 02:49 ET | 500 | 0.3167 |
| 02:51 ET | 700 | 0.3167 |
| 02:54 ET | 1100 | 0.3167 |
| 02:56 ET | 700 | 0.3167 |
| 02:58 ET | 700 | 0.3167 |
| 03:00 ET | 800 | 0.3167 |
| 03:02 ET | 3800 | 0.3167 |
| 03:03 ET | 600 | 0.32105 |
| 03:05 ET | 2100 | 0.32105 |
| 03:07 ET | 800 | 0.3196 |
| 03:09 ET | 800 | 0.32 |
| 03:12 ET | 12300 | 0.3184 |
| 03:14 ET | 400 | 0.32 |
| 03:16 ET | 1600 | 0.3187 |
| 03:18 ET | 400 | 0.3187 |
| 03:20 ET | 3100 | 0.3253 |
| 03:21 ET | 100 | 0.3227 |
| 03:30 ET | 5600 | 0.3227 |
| 03:38 ET | 100 | 0.3242 |
| 03:39 ET | 3016 | 0.3227 |
| 03:48 ET | 1230 | 0.322699 |
Today
DJ Forte Biosciences Is Maintained at Buy by Chardan Capital, from 7 hours ago by Dow Jones
7 hours ago by Dow Jones
Aug 14, 2024
*DJ Forte Biosciences 2Q Loss/Shr 27c >FBRX, from 4:01PM ET on Wednesday Aug 14, 2024 by Dow Jones
4:01PM ET on Wednesday Aug 14, 2024 by Dow JonesForte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update, from 4:01PM ET on Wednesday Aug 14, 2024 by Dow Jones
4:01PM ET on Wednesday Aug 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Forte Biosciences Inc | 11.0M | -0.4x | --- |
Check Cap Ltd | 10.9M | -0.6x | --- |
Kiora Pharmaceuticals Inc | 11.2M | --- | --- |
GlucoTrack Inc | 11.3M | -1.2x | --- |
Enzolytics Inc | 10.5M | 0.0x | --- |
Kintara Therapeutics Inc | 11.6M | -0.1x | --- |
Company Information
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases. The Company is advancing its product candidate, FB-102, which is a proprietary molecule with potentially broad autoimmune applications, including in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA). The Company’s FB-102 program focuses on addressing key pathways implicated in these indications with a CD122 antagonist. CD122 is a subunit of IL-2/IL-15 receptors which are key regulators of NK cells and T cell subsets. It owns one United States patent for administering a combination of Gram-positive and Gram-negative bacteria along with metabolites for treatment of a wide variety of skin conditions. The Company’s subsidiaries include Forte Subsidiary, Inc., Forte Biosciences Emerald Limited, and Forte Biosciences Australia Pty Ltd.
Contact Information
- Headquarters
- 3060 PEGASUS PARK DRIVE, BUILDING 6DALLAS, TX, United States 75247
- Phone
- 310-618-6994
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Paul Wagner
- Chief Financial Officer
- Antony Riley
- Independent Director
- Scott Brun
- Independent Director
- Stephen Doberstein
- Independent Director
- Lawrence Eichenfield
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $11.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 36.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.03 |
EPS | $-0.88 |
Book Value | $0.97 |
P/E Ratio | -0.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
